These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25682537)

  • 41. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.
    Tian G; Hindle M; Lee S; Longest PW
    Pharm Res; 2015 Oct; 32(10):3170-87. PubMed ID: 25944585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of flow field and turbulence predictions in a lung model applying RANS and implications for particle deposition.
    Sommerfeld M; Sgrott OL; Taborda MA; Koullapis P; Bauer K; Kassinos S
    Eur J Pharm Sci; 2021 Nov; 166():105959. PubMed ID: 34324962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of CT-derived ventilation maps with deposition patterns of inhaled microspheres in rats.
    Jacob RE; Lamm WJ; Einstein DR; Krueger MA; Glenny RW; Corley RA
    Exp Lung Res; 2015 Apr; 41(3):135-45. PubMed ID: 25513951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The distribution of inhaled particles in aerosol measurements of pulmonary airspace size.
    Rosenthal FS
    J Aerosol Med; 2000; 13(4):315-24. PubMed ID: 11262438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CFD simulation of aerosol delivery to a human lung via surface acoustic wave nebulization.
    Yousefi M; Pourmehran O; Gorji-Bandpy M; Inthavong K; Yeo L; Tu J
    Biomech Model Mechanobiol; 2017 Dec; 16(6):2035-2050. PubMed ID: 28735415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental methods for flow and aerosol measurements in human airways and their replicas.
    Lizal F; Jedelsky J; Morgan K; Bauer K; Llop J; Cossio U; Kassinos S; Verbanck S; Ruiz-Cabello J; Santos A; Koch E; Schnabel C
    Eur J Pharm Sci; 2018 Feb; 113():95-131. PubMed ID: 28842353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Artificial neural network prediction of the patterns of deposition of polydisperse aerosols within human lungs.
    Nazir J; Barlow DJ; Jayne Lawrence M; Shrubb I
    J Pharm Sci; 2005 Sep; 94(9):1986-97. PubMed ID: 16052546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters.
    Martonen TB; Katz IM
    Pharm Res; 1993 Jun; 10(6):871-8. PubMed ID: 8321856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model.
    Cassee FR; Muijser H; Duistermaat E; Freijer JJ; Geerse KB; Marijnissen JC; Arts JH
    Arch Toxicol; 2002 Jun; 76(5-6):277-86. PubMed ID: 12107645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physiological and pathological considerations for aerosol deposition: expiration and models of deposition.
    Smaldone GC
    J Aerosol Med; 2000; 13(4):387-91. PubMed ID: 11262445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. lapdMouse: associating lung anatomy with local particle deposition in mice.
    Bauer C; Krueger M; Lamm WJE; Glenny RW; Beichel RR
    J Appl Physiol (1985); 2020 Feb; 128(2):309-323. PubMed ID: 31774357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aerosol dispersion in human lung: comparison between numerical simulations and experiments for bolus tests.
    Darquenne C; Brand P; Heyder J; Paiva M
    J Appl Physiol (1985); 1997 Sep; 83(3):966-74. PubMed ID: 9292486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of simulated airway diseases and affected flow distributions on aerosol deposition.
    Apiou-Sbirlea G; Katz IM; Martonen TB
    Respir Care; 2010 Jun; 55(6):707-18. PubMed ID: 20507653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutual enhancements of CFD modeling and experimental data: a case study of 1-mum particle deposition in a branching airway model.
    Longest PW; Oldham MJ
    Inhal Toxicol; 2006 Sep; 18(10):761-71. PubMed ID: 16774865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computational model of particle deposition in the nasal cavity under steady and dynamic flow.
    Karakosta P; Alexopoulos AH; Kiparissides C
    Comput Methods Biomech Biomed Engin; 2015; 18(5):514-26. PubMed ID: 23971966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Model of the deposition of aerosol particles in the respiratory tract of the rat. II. Hygroscopic particle deposition.
    Ferron GA; Upadhyay S; Zimmermann R; Karg E
    J Aerosol Med Pulm Drug Deliv; 2013 Apr; 26(2):101-19. PubMed ID: 23550602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.
    Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and application of an aerosol screening model for size-resolved urban aerosols.
    Stanier CO; Lee SR;
    Res Rep Health Eff Inst; 2014 Jun; (179):3-79. PubMed ID: 25145039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modeling Airflow and Particle Deposition in a Human Acinar Region.
    Kolanjiyil AV; Kleinstreuer C
    Comput Math Methods Med; 2019; 2019():5952941. PubMed ID: 30755779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lung models: strengths and limitations.
    Martonen TB; Musante CJ; Segal RA; Schroeter JD; Hwang D; Dolovich MA; Burton R; Spencer RM; Fleming JS
    Respir Care; 2000 Jun; 45(6):712-36. PubMed ID: 10894463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.